Opportunity
DIBBS #SPE2DP-26-T-4348
DLA Solicitation for MOXIFLOXACIN HYDROCHLO Pharmaceuticals (TEVA, Rising Pharma)
Posted
July 29, 2026
Respond By
August 03, 2026
Identifier
SPE2DP-26-T-4348
NAICS
424210
This opportunity is a pharmaceutical procurement by the Defense Logistics Agency (DLA) for MOXIFLOXACIN HYDROCHLO: - Government Buyer: - Defense Logistics Agency (DLA) - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Vendors: - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - MOXIFLOXACIN HYDROCHLO (NSN 6505-01-503-4772) - TEVA: Part number NDC00093-7387-56, 10 units - RISING PHARMA: Part number NDC57237-0156-30, 10 units - Notable Requirements: - Only the specified OEMs and part numbers are approved for supply - The procurement is designated as a 'Fast Award' opportunity - No additional technical documents or attachments are provided
Description
MOXIFLOXACIN HYDROCHLO (QTY: 10, NSN: 6505-01-503-4772, Purchase Request: 7017651238) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.